Search Tag: androgen deprivation therapy
2021 30 Aug
Late-breaking research from the PRONOUNCE trial was presented in a Hot Line session at ESC Congress 2021. The cardiovascular safety of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the trial was terminated early. Every year, approximately one million men are diagnosed with prostate cancer worldwide. These patients...Read more
2014 08 Dec
According to a study published in JAMA, prescriptions for bisphosphonates, a class of drugs used to strengthen bone for men on androgen deprivation therapy (ADT) and for those at high risk of subsequent fractures, remain low despite guidelines recommending their use. ADT is widely used in men suffering from prostate cancer. Common adverse effects...Read more